Biomarkers in Alzheimer's disease

被引：0

作者：

Rajka M. Liscic ^{[1
,2
]}

Yuanhan Yang ^{[3
,4
,5
]}

机构：

[1] Clinic for Neurology,RH?N Clinics,Campus Bad Neustadt 2. Department of Anatomy and Neuroscience, School of Medicine, University of Osijek

[2] Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University

[3] Department of Master’s Program in Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University

[4] Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University

来源：

Brain Science Advances | 2016年 / 2卷 / 01期

关键词：

Alzheimer’s disease; biomarker;

D O I：

暂无

中图分类号：

R749.16 [];

学科分类号：

100203 ;

摘要：

Alzheimer’s disease(AD)so far did not have promising treatment.The accurate and early diagnosis is still the important issue.For these purpose,biomarkers related to diagnosis,clinical course,and other aims have been proposed and reported.Meanwhile,along with the ongoing researches for AD,biomarkers with their own aims are also on the way.

引用

页码：1 / 2

页数：2

共 2 条

[1]

Amyloid Imaging with ^sup 18^F-Florbetaben in Alzheimer Disease and Other Dementias[J] . Villemagne, Victor L,Ong, Kevin,Mulligan, Rachel S,Holl, Gerhard,Pejoska, Svetlana,Jones, Gareth,O’Keefe, Graeme,Ackerman, Uwe,Tochon-Danguy, Henri,Chan, J Gordon,Reininger, Cornelia B,Fels, Lueder,Putz, Barbara,Rohde, Beate,Masters, Colin L,Rowe, Christopher C.The Journal of Nuclear Medicine . 2011 (8)

[2]

Amyloid‐β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer’s Disease[J] . Alex L.Lublin,SamGandy.Mt Sinai J Med . 2010 (1)

← 1 →